Skip to Main Content

Paper Details

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.
Cell
43
2023
CD4, CD4 T cell, CTLA-4, Cancer, OX40, T cell, T cells, anti-tumorigenic neutrophil subset, antigen-loss-variant clones, melanoma, melanoma-specific CD4 T cell, melanomas, mice, mouse, neutrophil, neutrophils, nitric oxide, nitric oxide synthase, patients, tumor, tumor antigen, tumor-specific CD4 T cells, tumors
Author NameAffiliation
Andrew Chow
Travis J HollmannMemorial Sloan Kettering Cancer Center
Arshi AroraMemorial Sloan Kettering Cancer Center
Katherine S PanageasMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2